Lifevantage Corp (LFVN): Cash & Equivalents
$20.20M
As of 2025-06-30
0.0%
3-year compound annual growth
-1.8%
5-year compound annual growth
+3.8%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-06-30 | $20.20M | +19.6% | 2025-09-04, Balance as of period end |
| 2024-06-30 | $16.89M | -21.8% | 2025-09-04, Balance as of period end |
| 2023-06-30 | $21.61M | +7.0% | 2024-08-28, Balance as of period end |
| 2022-06-30 | $20.19M | -12.9% | 2023-08-28, Balance as of period end |
| 2021-06-30 | $23.17M | +4.7% | 2022-08-23, Balance as of period end |
| 2020-06-30 | $22.14M | +17.6% | 2021-08-19, Balance as of period end |
| 2019-06-30 | $18.82M | +13.0% | 2020-08-18, Balance as of period end |
| 2018-06-30 | $16.65M | +45.3% | 2019-08-14, Balance as of period end |
| 2017-06-30 | $11.46M | +45.4% | 2018-08-15, Balance as of period end |
| 2016-06-30 | $7.88M | -43.3% | 2018-08-15, Balance as of period end |
| 2015-06-30 | $13.90M | -31.8% | 2017-09-07, Balance as of period end |
| 2014-06-30 | $20.39M | -22.5% | 2016-12-12, Balance as of period end |
| 2013-06-30 | $26.30M | +6.7% | 2015-09-01, Balance as of period end |
| 2012-06-30 | $24.65M | +286.9% | 2014-09-10, Balance as of period end |
| 2011-06-30 | $6.37M | n/a | 2013-09-12, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Lifevantage Corp (LFVN) | 2025-06-30 | $20.20M | +19.6% |
| Stoke Therapeutics, Inc. (STOK) | 2025-12-31 | $84.22M | -34.2% |
| Maravai Lifesciences Holdings, Inc. (MRVI) | 2025-12-31 | $216.89M | -32.7% |
| Cryoport, Inc. (CYRX) | 2025-12-31 | $250.49M | +633.8% |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 2025-12-31 | $54.30M | -39.1% |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | $129.97M | -56.3% |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | $134.93M | -12.4% |
| Liquidia Corp (LQDA) | 2025-12-31 | $190.68M | +8.0% |
| Amarin Corp PLC (AMRN) | 2025-12-31 | $134.66M | +11.3% |
Compare LFVN, STOK, MRVI, CYRX side by side · Screen every company in Pharmaceutical Preparations ↗